Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2018 Filed Feb 7, 2018 20:25 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008290 · doc4.xml · derivative · entry 4 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:25 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Tax withholdingCommon Stock | 149 | $95.89 | $14,287.61 |
DisclosureSEC source: 0001209191-18-008290 · doc4.xml · nonDerivative · entry 2 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,260.8654 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:25 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionCommon Stock | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-008290 · doc4.xml · nonDerivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,409.8654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:24 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008289 · doc4.xml · derivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 375 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:24 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Tax withholdingCommon Stock | 112 | $95.89 | $10,739.68 |
DisclosureSEC source: 0001209191-18-008289 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,745 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:24 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionCommon Stock | 375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-008289 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:24 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionRestricted Stock Units · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008288 · doc4.xml · derivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:24 UTC |
Cuffe Michael S.President-Physician Services
|
Tax withholdingCommon Stock | 284 | $95.89 | $27,232.76 |
DisclosureSEC source: 0001209191-18-008288 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,089.4951 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:24 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 1,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-008288 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,373.4951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:23 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008287 · doc4.xml · derivative · entry 3 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:23 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Tax withholdingCommon Stock | 149 | $95.89 | $14,287.61 |
DisclosureSEC source: 0001209191-18-008287 · doc4.xml · nonDerivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:23 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
Exercise / conversionCommon Stock | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-008287 · doc4.xml · nonDerivative · entry 1 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 02, 2018 Filed Feb 2, 2018 20:12 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 5,000 | $100.93 | $504,664.00 |
DisclosureSEC source: 0001209191-18-007258 · doc4.xml · nonDerivative · entry 4 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,735 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.9256 to $100.9341, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
SaleCommon Stock | 6,545 | $101.54 | $664,579.30 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · nonDerivative · entry 7 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 02, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
SaleCommon Stock | 5,702 | $102.01 | $581,655.32 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 8 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.00 to $102.041, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:14 UTC |
Wyatt Christopher F.SVP & Controller
|
GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007261 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,157 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:10 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
SaleCommon Stock | 16,830 | $101.23 | $1,703,711.00 |
DisclosureSEC source: 0001209191-18-007254 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,386 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2015. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.065 to $101.5901, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:10 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
SaleCommon Stock | 13,365 | $100.76 | $1,346,646.71 |
DisclosureSEC source: 0001209191-18-007254 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,216 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2015. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.33 to $101.04, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,518 | $0.00 Strike: $15.91 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 20 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,518 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F11 · derivative.exercise_date: The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets. F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,829 | $0.00 Strike: $11.36 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 19 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,829 shares Expires 2019-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F10 · derivative.exercise_date: The option vested at the end of fiscal year 2012 based upon the achievement of certain annual EBITDA performance targets. F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,518 | $0.00 Strike: $10.92 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 18 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,518 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,829 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 17 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,829 shares Expires 2019-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,036 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 16 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,036 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F9 · derivative.exercise_date: The option vested at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets. F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,518 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 15 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,518 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,038 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 14 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,038 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F8 · derivative.exercise_date: The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013. F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 16,556 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 13 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,556 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F7 · derivative.exercise_date: The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested. F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,832 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 12 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,832 shares Expires 2019-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F5 · derivative.exercise_date: On February 25, 2009, the reporting person was granted an option to purchase 29,494 shares of common stock, which vest upon achievement of certain predetermined investment return targets. 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of the closing of the initial public offering of the Issuer's securities on March 15, 2011, 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2011 and 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2012. F6 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
SaleCommon Stock | 23,762 | $102.87 | $2,444,458.72 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 10 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,673 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.57 to $103.19, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
SaleCommon Stock | 24,700 | $101.98 | $2,518,982.57 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 9 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,435 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.58 to $102.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Tax withholdingCommon Stock | 14,976 | $102.24 | $1,531,146.24 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 8 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,135 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 5,518 | $15.91 | $87,798.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 7 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 9,829 | $11.36 | $111,642.70 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 6 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 5,518 | $10.92 | $60,238.90 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 5 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 9,829 | $7.47 | $73,460.96 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 4 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 16,554 | $6.48 | $107,223.57 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 3 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 27,594 | $5.98 | $165,070.07 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 9,832 | $5.34 | $52,488.13 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:52 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 17,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-007236 · doc4.xml · derivative · entry 9 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:52 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 17,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-007236 · doc4.xml · derivative · entry 8 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:52 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 37,500 | $0.00 Strike: $22.87 | $0.00 |
DisclosureSEC source: 0001209191-18-007236 · doc4.xml · derivative · entry 7 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2022-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:52 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 37,500 | $0.00 Strike: $22.87 | $0.00 |
DisclosureSEC source: 0001209191-18-007236 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2022-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on August 7, 2013. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:52 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 56,813 | $102.24 | $5,808,561.12 |
DisclosureSEC source: 0001209191-18-007236 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:52 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 35,000 | $22.95 | $803,250.00 |
DisclosureSEC source: 0001209191-18-007236 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:52 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 75,000 | $22.87 | $1,715,250.00 |
DisclosureSEC source: 0001209191-18-007236 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 640,070 | $0.00 Strike: $22.64 | $0.00 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 10 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 640,070 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.exercise_date: Two thirds of the option was vested upon grant on October 6, 2009, and one third of the option vested on November 17, 2009 F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 213,356 | $0.00 Strike: $17.65 | $0.00 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 9 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 213,356 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 213,365 | $0.00 Strike: $13.21 | $0.00 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · derivative · entry 8 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 213,365 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 543,348 | $102.24 | $55,551,899.52 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 5 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950,378 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 640,070 | $22.64 | $14,492,144.91 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 4 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,493,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 213,356 | $17.65 | $3,765,114.67 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 3 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 853,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.